Merit Medical Systems traded at $81.61 this Monday February 2nd, increasing $0.52 or 0.64 percent since the previous trading session. Looking back, over the last four weeks, Merit Medical Systems gained 8.73 percent. Over the last 12 months, its price fell by 23.92 percent. Looking ahead, we forecast Merit Medical Systems to be priced at 78.59 by the end of this quarter and at 71.55 in one year, according to Trading Economics global macro models projections and analysts expectations.
Merit Medical Systems, Inc. designs, develops, manufactures and markets medical products for interventional and diagnostic procedures. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.